Ibrain : Impact Factor & More
eISSN: 2769-2795pISSN: 2313-1934
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Ibrain Journal Specifications
| Overview | |
| Publisher | Wiley-VCH |
| Language | English |
| Article Processing Charges | USD 2800 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Affiliated Hospital of Zunyi Medical University |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Ibrain ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Ibrain
Berberine alleviates cell pyroptosis in diabetic retinopathy by regulating AKT1, JUN, and STAT3
- 26 Mar 2026
- Ibrain
Impact of early dexmedetomidine administration on short- and long-term outcomes in critically traumatic brain injury patients: A retrospective study using the MIMIC-IV database.
- 1 Mar 2026
- Ibrain
Preclinical advances in antibodies against N-terminal Aβ4-x species for Alzheimer's disease and cerebral amyloid angiopathy.
- 1 Mar 2026
- Ibrain
Title not available
- 1 Mar 2026
- Ibrain
Issue Information
- 1 Mar 2026
- Ibrain
Development of a predictive model for depressive symptoms in type 2 diabetes mellitus patients under community management: Based on visual function index.
- 12 Feb 2026
- Ibrain
Berberine alleviates cell pyroptosis in diabetic retinopathy by regulating AKT1, JUN, and STAT3
- 26 Mar 2026
- Ibrain
Impact of early dexmedetomidine administration on short- and long-term outcomes in critically traumatic brain injury patients: A retrospective study using the MIMIC-IV database.
- 1 Mar 2026
- Ibrain
Preclinical advances in antibodies against N-terminal Aβ4-x species for Alzheimer's disease and cerebral amyloid angiopathy.
- 1 Mar 2026
- Ibrain
Title not available
- 1 Mar 2026
- Ibrain
Issue Information
- 1 Mar 2026
- Ibrain
Development of a predictive model for depressive symptoms in type 2 diabetes mellitus patients under community management: Based on visual function index.
- 12 Feb 2026
- Ibrain
FAQs on Ibrain
How many articles did Ibrain publish last year? 
What is the eISSN & pISSN for Ibrain?
Who is the publisher of Ibrain?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations